AEMD Aethlon Medical, Inc. Stock Quote

Your browser is no longer supported. Please, upgrade your browser.

publish chart | save to portfolio | create alert

Settings

AEMD [NASD]

Aethlon Medical, Inc.

Healthcare | Medical Devices | USA

statements

Index	-	P/E	-	EPS (ttm)	-3.42	Insider Own	1.30%	Shs Outstand	8.20M	Perf Week	3.93%
Market Cap	21.77M	Forward P/E	-	EPS next Y	-0.39	Insider Trans	0.00%	Shs Float	-	Perf Month	30.28%
Income	-6.40M	PEG	-	EPS next Q	-	Inst Own	11.20%	Short Float	-	Perf Quarter	21.71%
Sales	0.70M	P/S	31.11	EPS this Y	63.60%	Inst Trans	-	Short Ratio	0.28	Perf Half Y	97.33%
Book/sh	1.15	P/B	1.61	EPS next Y	-	ROA	-132.20%	Target Price	-	Perf Year	-71.97%
Cash/sh	0.82	P/C	2.27	EPS next 5Y	-	ROE	-174.20%	52W Range	0.76 - 6.89	Perf YTD	92.11%
Dividend	-	P/FCF	-	EPS past 5Y	36.60%	ROI	-67.80%	52W High	-73.15%	Beta	0.67
Dividend %	-	Quick Ratio	9.40	Sales past 5Y	-3.10%	Gross Margin	-	52W Low	142.15%	ATR	0.27
Employees	8	Current Ratio	9.40	Sales Q/Q	100.00%	Oper. Margin	-	RSI (14)	50.91	Volatility	10.87% 14.73%
Optionable	No	Debt/Eq	0.00	EPS Q/Q	83.30%	Profit Margin	-	Rel Volume	0.16	Prev Close	1.92
Shortable	Yes	LT Debt/Eq	0.00	Earnings	Jun 25 AMC	Payout	-	Avg Volume	2.52M	Price	1.85
Recom	2.00	SMA20	-7.80%	SMA50	14.47%	SMA200	-19.81%	Volume	390,379	Change	-3.65%

Jun-30-20 09:21AM	Edited Transcript of AEMD earnings conference call or presentation 25-Jun-20 8:30pm GMT Thomson Reuters StreetEvents
Jun-25-20 04:15PM	Aethlon Medical Announces Fiscal Year Financial Results and Provides Corporate Update PR Newswire +6.22%
02:30PM	Aethlon Medical, Inc. to Host Earnings Call ACCESSWIRE
Jun-22-20 08:31AM	Aethlon Medical Presents Hemopurifier® Data at the American Association for Cancer Research 2020 Annual Meeting PR Newswire -13.96%
Jun-18-20 12:49PM	FDA Backs Testing of Device Once Flagged for Covid Speculation Bloomberg +89.36%
09:19AM	Aethlon Announces FDA Approval of IDE Supplement for COVID-19 Patients PR Newswire
Jun-16-20 08:30AM	Aethlon Medical To Release Fourth Quarter Financial Results and Host Conference Call on June 25, 2020 PR Newswire
Mar-24-20 08:58AM	Aethlon Announces Issuance of European Patent for the Hemopurifier® in Cancer PR Newswire -8.78%
Mar-06-20 12:08PM	AEMD: Coronavirus 2019 (COVID-19) Could Represent New Opportunity for AEMD Zacks Small Cap Research +7.62%
Feb-25-20 03:25PM	18 Medical Stocks To Watch Amid The Coronavirus Outbreak Benzinga -17.55%
Feb-24-20 10:22AM	Securities and Exchange Commission (SEC) Order for Halt in trading of Aethlon Medical Stock Expires PR Newswire -5.04%
Feb-17-20 01:37PM	Edited Transcript of AEMD earnings conference call or presentation 10-Feb-20 9:30pm GMT Thomson Reuters StreetEvents
Feb-13-20 05:35AM	Investors Who Bought Aethlon Medical (NASDAQ:AEMD) Shares Five Years Ago Are Now Down 98% Simply Wall St.
Feb-10-20 04:15PM	Aethlon Medical Announces Third Quarter Financial Results and Provides Corporate Update PR Newswire
09:01AM	Securities and Exchange Commission (SEC) Order for Halt in trading of Aethlon Medical (NASDAQ:AEMD) Stock PR Newswire
Feb-06-20 08:01AM	Aethlon Medical To Release Third Quarter Financial Results and Host Conference Call on February 10, 2020 PR Newswire
Jan-23-20 01:02PM	13 Coronavirus-Related Stocks To Watch Amid Wuhan Outbreak Benzinga
09:51AM	The Zacks Analyst Blog Highlights: Novavax, NanoViricides, Aethlon Medical and Oncolytics Biotech Zacks
Jan-22-20 02:28PM	Health stocks reverse coronavirus gains as one analyst says the market is overreacting Yahoo Finance +14.29%
01:16PM	Aethlon Medical Announces Completion of $3.77 Million Registered Direct Offering PR Newswire
08:12AM	Coronavirus Infects Wall Street: Stocks to Gain & Lose Zacks
Jan-21-20 02:40PM	Experimental vaccine stocks jump on concerns about new virus in China MarketWatch +12.14%
Jan-17-20 08:49AM	Aethlon Medical Announces $3.77 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules PR Newswire -25.36%
Dec-17-19 04:18PM	Aethlon Medical Announces Closing of $5 Million Public Offering PR Newswire -6.50%
Dec-13-19 07:00AM	Aethlon Medical Announces Pricing of $5 Million Public Offering PR Newswire -47.85%
Nov-15-19 05:04AM	Here's Why We Worry About Aethlon Medical's (NASDAQ:AEMD) Cash Burn Situation Simply Wall St.
Nov-01-19 04:15PM	Aethlon Medical Announces Second Quarter Financial Results and Provides Corporate Update PR Newswire -10.00%
Oct-29-19 03:17PM	Aethlon Medical To Release Second Quarter Financial Results and Host Conference Call on November 1, 2019 PR Newswire -15.42%
Oct-28-19 07:00AM	AEMD: IDE Approved. Hemopurifier U.S. Clinical Cancer Program On-Deck Zacks Small Cap Research
Oct-14-19 03:55PM	Aethlon Announces Reverse Stock Split PR Newswire

Aethlon Medical, Inc., a medical technology company, focuses on developing products to diagnose and treat life and organ threatening diseases in the United States. The company is developing Aethlon Hemopurifier, a clinical-stage immunotherapeutic device that removes exosomes and life-threatening viruses from the human circulatory system. It is also developing TauSome, an exosomal biomarker candidate to diagnose chronic traumatic encephalopathy in living individuals. The company is based in San Diego, California.

open in yahoo | open in reuters | open in google

Upgrade your FINVIZ experience